Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 19 Oct 2026 | 3,500 | 5,945 (0%) | 0% | 18 | 63,000 | - |
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | 19 Oct 2026 | 3,500 | 2,445 (0%) | 0% | 0 | - | ||
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | 19 Oct 2026 | 3,500 | 109,327 (1%) | 0% | 0 | - | ||
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.00 per share. | 19 Oct 2026 | 3,500 | 5,945 (0%) | 0% | 24 | 84,000 | - |
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | 19 Oct 2026 | 3,500 | 2,445 (0%) | 0% | 0 | - | ||
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | 19 Oct 2026 | 3,500 | 112,827 (1%) | 0% | 0 | - | ||
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.83 per share. | 19 Oct 2026 | 2,800 | 5,245 (0%) | 0% | 28.8 | 80,724 | - |
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.87 per share. | 19 Oct 2026 | 2,800 | 2,445 (0%) | 0% | 51.9 | 145,236 | - |
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.79 per share. | 19 Oct 2026 | 2,100 | 4,545 (0%) | 0% | 25.8 | 54,159 | - |
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.87 per share. | 19 Oct 2026 | 2,070 | 2,475 (0%) | 0% | 51.9 | 107,371 | - |
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.22 per share. | 19 Oct 2026 | 2,000 | 4,445 (0%) | 0% | 37.2 | 74,440 | - |
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.87 per share. | 19 Oct 2026 | 2,000 | 2,445 (0%) | 0% | 51.9 | 103,740 | - |
| Equity Bancshares Inc (Class A) | Mr. Leon H. Borck | Director | Purchase of securities on an exchange or from another person at price $ 48.78 per share. | 19 Oct 2026 | 380 | 96,320 (0%) | 0% | 48.8 | 18,536 | - |
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | 19 Oct 2026 | 30 | 2,445 (0%) | 0% | 0 | - | ||
| Weyco Grp Inc | Mr. Frederick P. Stratton, Jr | Director | 19 Oct 2026 | 30 | 112,857 (1%) | 0% | 0 | - | ||
| Standard Nuclear Inc | Mr. Kurt Terrani | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.17 per share. | 17 Oct 2026 | 110,014 | 5,876,862 | - | 12.2 | 1,338,870 | - |
| Standard Nuclear Inc | Mr. Thomas Hendrix | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.17 per share. | 17 Oct 2026 | 95,590 | 2,639,097 | - | 12.2 | 1,163,330 | - |
| Standard Nuclear Inc | Mr. Kevin J. Harrill | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.17 per share. | 17 Oct 2026 | 32,715 | 1,555,444 | - | 12.2 | 398,142 | - |
| Standard Nuclear Inc | Ms. Keeley Marrocco | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.17 per share. | 17 Oct 2026 | 7,399 | 3,557,226 | - | 12.2 | 90,046 | - |
| Applied Digital Corp | Mr. Jason Zhang | President | Purchase of securities on an exchange or from another person at price $ 18.86 per share. | 16 Oct 2026 | 300,000 | 2,839,227 | - | 18.9 | 5,658,000 | - |
| Applied Digital Corp | Mr. Wesley Cummins | Director, CEO; Chairman | Purchase of securities on an exchange or from another person at price $ 18.04 per share. | 16 Oct 2026 | 55,803 | 5,874,453 | - | 18.0 | 1,006,686 | - |
| Mirum Pharma Inc | Mr. Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.24 per share. | 16 Oct 2026 | 16,112 | 16,728 (0%) | 0% | 19.2 | 309,995 | - |
| FingerMotion Inc | Mr. Chris Polimeni | CFO | Purchase of securities on an exchange or from another person at price $ 0.18 per share. | 16 Oct 2026 | 13,500 | 13,500 | - | 0.2 | 2,469 | - |
| PubMatic Inc Ordinary Shares | Mr. Mukul Kumar | PRESIDENT, ENGINEERING | 16 Oct 2026 | 8,000 | 133,041 | - | 0 | - | ||
| Wise Group Plc Ordinary | Mr. Emmanuel Thomassin | Chief Financial Officer and Director | 16 Oct 2026 | 6,040 | 4,853 (0%) | 0% | 11.8 | 70,983 | - | |
| PubMatic Inc Ordinary Shares | Mr. Mukul Kumar | PRESIDENT, ENGINEERING | Sale of securities on an exchange or to another person at price $ 16.80 per share. | 16 Oct 2026 | 5,400 | 125,041 | - | 16.8 | 90,744 | - |
| Karyopharm Therapeutics Inc | Ms. Kristin Abate | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.34 per share. | 16 Oct 2026 | 4,788 | 18,616 (0%) | 0% | 0.3 | 1,647 | - |
| X4 Pharma Inc | Dr. Adam Raymond Craig, M.B.A.,M.D.,PhD | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 2.58 per share. | 16 Oct 2026 | 4,600 | 333,251 (2%) | 0% | 2.6 | 11,884 | - |
| Mastercard | Mr. Hai Ling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 112.31 per share. | 16 Oct 2026 | 4,317 | 40,067 (0%) | 0% | 112.3 | 484,842 | - |
| Mastercard | Mr. Hai Ling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 620.00 per share. | 16 Oct 2026 | 4,317 | 35,750 (0%) | 0% | 620 | 2,676,540 | - |
| American International | Mr. Edward Lee Dandridge | EVP, Chief Marketing & Comms | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2026 | 2,813 | 14,327 (0%) | 0% | 0 | - | |
| PubMatic Inc Ordinary Shares | Mr. Mukul Kumar | PRESIDENT, ENGINEERING | Sale of securities on an exchange or to another person at price $ 17.78 per share. | 16 Oct 2026 | 2,600 | 117,041 | - | 17.8 | 46,240 | - |
| Bandwidth Inc (Class A) | Mr. Lukas M. Roush | Director | Sale of securities on an exchange or to another person at price $ 49.04 per share. | 16 Oct 2026 | 1,500 | 58,769 (0%) | 0% | 49.0 | 73,560 | - |
| American International | Mr. Edward Lee Dandridge | EVP, Chief Marketing & Comms | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.74 per share. | 16 Oct 2026 | 1,437 | 12,890 (0%) | 0% | 80.7 | 116,023 | - |
| Oil-Dri Corp Of America | Ms. Amy L. Ryan | Director | Sale of securities on an exchange or to another person at price $ 78.80 per share. | 16 Oct 2026 | 1,100 | 2,800 (0%) | 0% | 78.8 | 86,680 | - |
| Kulicke & Soffa Ind Inc | Mr. Robert Nestor Chylak | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.63 per share. | 16 Oct 2026 | 1,029 | 32,104 (0%) | 0% | 78.6 | 80,910 | - |
| Williams-Sonoma | Ms. Anne M. Finucane | Director | Sale of securities on an exchange or to another person at price $ 252.12 per share. | 16 Oct 2026 | 780 | 9,418 (0%) | 0% | 252.1 | 196,654 | - |
| Kingsway Corp | Mr. Kent A. Hansen | CFO & EVP | Purchase of securities on an exchange or from another person at price $ 9.74 per share. | 16 Oct 2026 | 160 | 136,832 (0%) | 0% | 9.7 | 1,558 | - |
| York Water Co. | Mr. Joseph T. Hand | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 29.17 per share. | 16 Oct 2026 | 120 | 35,693 (0%) | 0% | 29.2 | 3,500 | - |
| York Water Co. | Mr. Matthew J. Scarpato | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 29.17 per share. | 16 Oct 2026 | 120 | 2,832 (0%) | 0% | 29.2 | 3,500 | - |
| York Water Co. | Ms. Suzanne M. Becker | VP- Customer Service | Grant, award, or other acquisition of securities at price $ 29.17 per share. | 16 Oct 2026 | 48 | 425 (0%) | 0% | 29.2 | 1,400 | - |
| York Water Co. | Ms. Alexandra C. Chiaruttini, Esq. | CAO & General Counsel | Grant, award, or other acquisition of securities at price $ 29.17 per share. | 16 Oct 2026 | 48 | 6,023 (0%) | 0% | 29.2 | 1,400 | - |
| Williams-Sonoma | Ms. Anne M. Finucane | Director | Sale of securities on an exchange or to another person at price $ 253.14 per share. | 16 Oct 2026 | 14 | 9,404 (0%) | 0% | 253.1 | 3,544 | - |
| York Water Co. | Mr. Mark S Snyder, P.E. | VP- Engineering | Grant, award, or other acquisition of securities at price $ 29.17 per share. | 16 Oct 2026 | 12 | 4,980 (0%) | 0% | 29.2 | 350 | - |
| York Water Co. | Mr. Matthew E. Poff, C.P.A. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 35.00 per share. | 16 Oct 2026 | 4 | 9,609 (0%) | 0% | 35 | 140 | - |
| Acushnet Holdings Corp | Mr. Ho Yeon Aaron Lee | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 89.97 per share. | 15 Oct 2026 | 583,527 | 28,940,126 (38%) | 0% | 90.0 | 52,501,033 | - |
| Acushnet Holdings Corp | Mr. Yoon Soon Gene Yoon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 89.97 per share. | 15 Oct 2026 | 583,527 | 28,940,126 (38%) | 0% | 90.0 | 52,501,033 | - |
| Acushnet Holdings Corp | Mr. Keun Chang Kevin Yoon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 89.97 per share. | 15 Oct 2026 | 583,527 | 28,940,126 (38%) | 0% | 90.0 | 52,501,033 | - |
| Netskope Inc Ordinary | Ms. Kimberly E. Alexy | Director | 15 Oct 2026 | 421,600 | 421,600 | - | - | - | ||
| Nextdoor Holdings Inc (Class A) | Mr. Nirav Tolia | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 313,126 | 2,413,477 | - | 0 | - | |
| Frazier Life Sciences | Dr. Albert Cha, M.D.,PhD | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 15 Oct 2026 | 300,000 | 300,000 | - | 10 | 3,000,000 | - |
| Fossil Grp Inc | Mr. Franco Fogliato | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.90 per share. | 15 Oct 2026 | 295,125 | 1,726,875 (3%) | 0% | 6.9 | 2,036,363 | - |
| Moleculin Biotech Inc | Mr. Walter V. Klemp | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 207,500 | 771,840 (1%) | 0% | - | - | |
| Global Net Lease Inc | Mr. Edward M. Weil, Jr | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 200,585 | 3,065,225 (3%) | 0% | 0 | - | |
| Travere Therapeutics Inc | Dr. Eric M. Dube, PhD | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.93 per share. | 15 Oct 2026 | 200,000 | 676,621 (1%) | 0% | 8.9 | 1,786,000 | - |
| Ribbon Communications Inc | Mr. Shaul Shani | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 185,210 | 438,553 (0%) | 0% | - | - | |
| Nextdoor Holdings Inc (Class A) | Mr. Craig Lisowski | President of Products | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 178,571 | 1,902,694 | - | 0 | - | |
| Moleculin Biotech Inc | Mr. Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 130,000 | 435,673 (0%) | 0% | - | - | |
| Travere Therapeutics Inc | Dr. Eric M. Dube, PhD | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 52.97 per share. | 15 Oct 2026 | 128,065 | 548,556 (1%) | 0% | 53.0 | 6,783,244 | - |
| Nextdoor Holdings Inc (Class A) | Mr. Nirav Tolia | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 123,216 | 2,290,261 | - | 2.6 | 320,362 | - |
| Ethos Technologies Inc | Mr. Lingke Wang | Director, President | 15 Oct 2026 | 118,333 | 1,655,876 | - | - | - | ||
| GoodRx Holdings Inc (Class A) | Ms. Wendy Barnes | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 115,149 | 856,806 | - | - | - | |
| GoodRx Holdings Inc (Class A) | Ms. Wendy Barnes | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 110,963 | 946,693 | - | - | - | |
| Nextdoor Holdings Inc (Class A) | Mr. Nirav Tolia | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 110,521 | 2,428,150 | - | 0 | - | |
| Global Net Lease Inc | Mr. Edward M. Weil, Jr | Director, CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. | 15 Oct 2026 | 104,906 | 2,960,319 (3%) | 0% | 7.4 | 780,501 | - |
| Nexentis Technologies Inc | Mr. Amitay Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 101,549 | 120,000 | - | 0 | - | |
| Nexentis Technologies Inc | Mr. David Palach | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 101,549 | 120,000 | - | 0 | - | |
| Ethos Technologies Inc | Mr. Lingke Wang | Director, President | Sale of securities on an exchange or to another person at price $ 38.52 per share. | 15 Oct 2026 | 94,864 | 1,538,343 | - | 38.5 | 3,654,161 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Sophia Schwartz | Chief Legal Officer, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 91,667 | 428,564 | - | 0 | - | |
| Nextdoor Holdings Inc (Class A) | Mr. Craig Lisowski | President of Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 90,679 | 1,812,015 | - | 2.6 | 235,765 | - |
| Travere Therapeutics Inc | Dr. Eric M. Dube, PhD | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.02 per share. | 15 Oct 2026 | 78,400 | 432,886 (1%) | 0% | 55.0 | 4,313,403 | - |
| MapLight Therapeutics Inc | Dr. Christopher A. Kroeger, M.D. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.08 per share. | 15 Oct 2026 | 73,691 | 1,195,909 | - | 8.1 | 595,423 | - |
| Global Net Lease Inc | Mr. Christopher J. Masterson | CFO, Secretary and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 73,549 | 359,440 (0%) | 0% | 0 | - | |
| Nextdoor Holdings Inc (Class A) | Mr. Craig Lisowski | President of Products | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 72,674 | 1,884,689 | - | 0 | - | |
| Champions Oncology Inc | Mr. Joel Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.60 per share. | 15 Oct 2026 | 69,794 | 1,126,333 (9%) | 0% | 1.6 | 111,670 | - |
| Chime Fin Inc (Class A) | Mr. Christopher Britt | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.00 per share. | 15 Oct 2026 | 67,438 | 292,979 | - | 29 | 1,955,702 | - |
| Fossil Grp Inc | Mr. Randy J. Greben | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 65,217 | 230,329 (0%) | 0% | 0 | - | |
| Fossil Grp Inc | Ms. Melissa B. Lowenkron | Chief Brand Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 65,217 | 156,983 (0%) | 0% | 0 | - | |
| Nextdoor Holdings Inc (Class A) | Mr. Michael Kiernan | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 65,000 | 523,602 | - | 0 | - | |
| Clover Health Investments Corp (Class A) | Mr. Andrew Toy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.68 per share. | 15 Oct 2026 | 62,176 | 9,078,334 | - | 4.7 | 290,984 | - |
| Chime Fin Inc (Class A) | Mr. Christopher Britt | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Oct 2026 | 57,562 | 235,417 | - | 0 | - | |
| Chime Fin Inc (Class A) | Mr. Christopher Britt | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Oct 2026 | 57,562 | 57,562 | - | 0 | - | |
| D-Wave Quantum Inc | Dr. Alan Baratz | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.03 per share. | 15 Oct 2026 | 52,320 | 3,195,131 | - | 12.0 | 629,410 | - |
| GoodRx Holdings Inc (Class A) | Ms. Wendy Barnes | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 51,177 | 857,962 | - | - | - | |
| Nexentis Technologies Inc | Mr. Shlomo Zakai | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 51,000 | 60,256 | - | 0 | - | |
| Nexentis Technologies Inc | Ms. Lital Barda | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 51,000 | 60,198 | - | 0 | - | |
| GoodRx Holdings Inc (Class A) | Ms. Wendy Barnes | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.38 per share. | 15 Oct 2026 | 50,021 | 806,785 | - | 3.4 | 169,071 | - |
| Montana Tech Corp (Class A) | Mr. Matthew B. Jore | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.06 per share. | 15 Oct 2026 | 50,000 | 7,698,020 | - | 3.1 | 153,165 | - |
| Natera Inc | Dr. Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.41 per share. | 15 Oct 2026 | 50,000 | 2,169,394 (2%) | 0% | 10.4 | 520,500 | - |
| Medtronic | Mr. Geoffrey S. Martha | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 15 Oct 2026 | 50,000 | 277,866 (0%) | 0% | 95 | 4,750,000 | - |
| Moleculin Biotech Inc | Mr. Walter V. Klemp | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 15 Oct 2026 | 48,659 | 723,181 (1%) | 0% | 0.4 | 18,009 | - |
| Global Net Lease Inc | Mr. Ori Kravel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 48,476 | 278,516 (0%) | 0% | 0 | - | |
| Global Net Lease Inc | Mr. Jesse Charles Galloway | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 48,476 | 294,822 (0%) | 0% | 0 | - | |
| GoodRx Holdings Inc (Class A) | Ms. Wendy Barnes | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.38 per share. | 15 Oct 2026 | 48,203 | 898,490 | - | 3.4 | 162,926 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Sophia Schwartz | Chief Legal Officer, Secretary | Sale of securities on an exchange or to another person at price $ 2.51 per share. | 15 Oct 2026 | 48,120 | 360,324 | - | 2.5 | 120,709 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Sophia Schwartz | Chief Legal Officer, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 46,549 | 382,015 | - | 2.6 | 121,027 | - |
| Nextdoor Holdings Inc (Class A) | Mr. Nirav Tolia | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 45,126 | 2,335,387 | - | 0 | - | |
| StoneX Grp Inc | Mr. Philip Andrew Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.90 per share. | 15 Oct 2026 | 45,000 | 783,216 (4%) | 0% | 8.9 | 400,500 | - |
| StoneX Grp Inc | Mr. Philip Andrew Smith | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.50 per share. | 15 Oct 2026 | 45,000 | 738,216 (3%) | 0% | 59.5 | 2,677,487 | - |
| Travere Therapeutics Inc | Dr. Eric M. Dube, PhD | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.88 per share. | 15 Oct 2026 | 43,735 | 476,621 (1%) | 0% | 26.9 | 1,175,597 | - |
| Nextdoor Holdings Inc (Class A) | Mr. Nirav Tolia | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 43,491 | 2,384,659 | - | 2.6 | 113,077 | - |
| Nextdoor Holdings Inc (Class A) | Mr. Craig Lisowski | President of Products | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 41,445 | 1,889,230 | - | 0 | - | |
| Rave Restaurant Group Inc | Mr. Brandon L. Solano | CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 41,344 | 636,495 (4%) | 0% | 0 | - | |
| Planet Labs PBC (Class A) | Ms. Kristen O. Robinson | Director | Sale of securities on an exchange or to another person at price $ 14.14 per share. | 15 Oct 2026 | 40,000 | 182,897 | - | 14.1 | 565,560 | - |
| Amplitude Inc (Class A) | Mr. Vijaye Ganesh Raji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 37,851 | 37,851 | - | 0 | - | |
| Chime Fin Inc (Class A) | Mr. Ryan King | Director, Co-Founder | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Oct 2026 | 37,812 | 116,667 | - | 0 | - | |
| Chime Fin Inc (Class A) | Mr. Ryan King | Director, Co-Founder | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Oct 2026 | 37,812 | 37,812 | - | 0 | - | |
| Global Net Lease Inc | Mr. Christopher J. Masterson | CFO, Secretary and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. | 15 Oct 2026 | 37,547 | 321,893 (0%) | 0% | 7.4 | 279,350 | - |
| Ribbon Communications Inc | Mr. Eric Marmurek | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 37,500 | 581,206 (0%) | 0% | - | - | |
| Travere Therapeutics Inc | Dr. Eric M. Dube, PhD | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 54.20 per share. | 15 Oct 2026 | 37,270 | 511,286 (1%) | 0% | 54.2 | 2,020,023 | - |
| Chime Fin Inc (Class A) | Mr. Ryan King | Director, Co-Founder | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.00 per share. | 15 Oct 2026 | 37,188 | 154,479 | - | 29 | 1,078,452 | - |
| Nextdoor Holdings Inc (Class A) | Mr. Craig Lisowski | President of Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 36,904 | 1,847,785 | - | 2.6 | 95,950 | - |
| GoodRx Holdings Inc (Class A) | Mr. Justin Fengler | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 32,490 | 84,999 | - | - | - | |
| Moleculin Biotech Inc | Mr. Jonathan P. Foster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 15 Oct 2026 | 30,485 | 405,188 (0%) | 0% | 0.4 | 11,282 | - |
| Nextdoor Holdings Inc (Class A) | Mr. Michael Kiernan | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 30,036 | 493,566 | - | 2.6 | 78,094 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Sophia Schwartz | Chief Legal Officer, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 29,473 | 423,411 | - | 0 | - | |
| Kelly Services Inc (Class A) | Mr. Troy R. Anderson | Executive Vice President, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.57 per share. | 15 Oct 2026 | 27,716 | 201,770 (0%) | 0% | 15.6 | 431,538 | - |
| Nextdoor Holdings Inc (Class A) | Mr. Michael Kiernan | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 27,631 | 521,197 | - | 0 | - | |
| Global Net Lease Inc | Mr. Ori Kravel | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. | 15 Oct 2026 | 26,032 | 252,484 (0%) | 0% | 7.4 | 193,678 | - |
| Global Net Lease Inc | Mr. Jesse Charles Galloway | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. | 15 Oct 2026 | 25,353 | 269,469 (0%) | 0% | 7.4 | 188,626 | - |
| Aquestive Therapeutics Inc | Mr. Daniel Barber | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.22 per share. | 15 Oct 2026 | 25,000 | 627,317 (1%) | 0% | 4.2 | 105,600 | - |
| Beam Therapeutics Inc | Mr. John Evans | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 15 Oct 2026 | 25,000 | 1,072,205 (2%) | 0% | 1.0 | 25,750 | - |
| Beam Therapeutics Inc | Mr. John Evans | Director, CEO | Sale of securities on an exchange or to another person at price $ 23.57 per share. | 15 Oct 2026 | 25,000 | 1,047,205 (2%) | 0% | 23.6 | 589,150 | - |
| Beam Therapeutics Inc | Mr. John Evans | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 15 Oct 2026 | 25,000 | 1,072,205 (2%) | 0% | 1.0 | 25,750 | - |
| Beam Therapeutics Inc | Mr. John Evans | Director, CEO | Sale of securities on an exchange or to another person at price $ 23.98 per share. | 15 Oct 2026 | 25,000 | 1,047,205 (2%) | 0% | 24.0 | 599,595 | - |
| Rave Restaurant Group Inc | Mr. Brandon L. Solano | CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. | 15 Oct 2026 | 24,281 | 636,495 (4%) | 0% | 2.2 | 52,690 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Sophia Schwartz | Chief Legal Officer, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 24,225 | 406,240 | - | 0 | - | |
| Clover Health Investments Corp (Class A) | Mr. Conard Wai | CEO, Counterpart Health | Sale of securities on an exchange or to another person at price $ 4.68 per share. | 15 Oct 2026 | 23,627 | 1,042,072 | - | 4.7 | 110,574 | - |
| Ethos Technologies Inc | Mr. Lingke Wang | Director, President | Sale of securities on an exchange or to another person at price $ 37.64 per share. | 15 Oct 2026 | 22,669 | 1,633,207 | - | 37.6 | 853,261 | - |
| GoodRx Holdings Inc (Class A) | Ms. Wendy Barnes | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.38 per share. | 15 Oct 2026 | 22,232 | 835,730 | - | 3.4 | 75,144 | - |
| Nextdoor Holdings Inc (Class A) | Mr. Craig Lisowski | President of Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 21,046 | 1,868,184 | - | 2.6 | 54,720 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Antoinette How | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.49 per share. | 15 Oct 2026 | 20,705 | 0 | - | 2.5 | 51,531 | - |
| Nexentis Technologies Inc | Mr. Eliahou Arbib | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 19,375 | 19,640 | - | 0 | - | |
| Nexentis Technologies Inc | Mr. Ronen Rosenbloom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 19,375 | 19,640 | - | 0 | - | |
| Nexentis Technologies Inc | Mr. Israel Yakov Berenstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 19,375 | 19,640 | - | 0 | - | |
| Ribbon Communications Inc | Mr. Bruns H. Grayson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 19,176 | 859,446 (0%) | 0% | - | - | |
| QUALCOMM | Mr. Cristiano R. Amon | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 19,053 | 196,719 (0%) | 0% | 0 | - | |
| Worthington Steel Inc | Mr. Clifford J. Larivey | President Flat Rolled Stl Proc | Sale of securities on an exchange or to another person at price $ 40.31 per share. | 15 Oct 2026 | 18,370 | 33,519 | - | 40.3 | 740,542 | - |
| Clover Health Investments Corp (Class A) | Ms. Jamie L. Reynoso | CEO, Medicare Advantage | Sale of securities on an exchange or to another person at price $ 4.68 per share. | 15 Oct 2026 | 18,273 | 2,774,417 | - | 4.7 | 85,518 | - |
| Bank of America | Mr. Brian T. Moynihan | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 18,083 | 2,717,695 (0%) | 0% | - | - | |
| Bank of America | Mr. Brian T. Moynihan | Director, Chair and CEO | Sale or transfer of securities back to the company at price $ 51.70 per share. | 15 Oct 2026 | 18,083 | 2,699,612 (0%) | 0% | 51.7 | 934,891 | - |
| Nextdoor Holdings Inc (Class A) | Mr. Nirav Tolia | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 17,758 | 2,317,629 | - | 2.6 | 46,171 | - |
| Federated Hermes Inc (Class B) | Mr. Thomas R. Donahue | Director, VP, CFO & Treasurer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Oct 2026 | 17,670 | 542,622 (0%) | 0% | 0 | - | |
| TD Synnex Corp | Mr. Patrick Laurent Zammit | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 17,441 | 180,214 (0%) | 0% | 0 | - | |
| Chewy Inc (Class A) | Mr. William G. Billings | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 15 Oct 2026 | 17,283 | 39,772 (0%) | 0% | 21 | 362,943 | - |
| GrabAGun Digital Holdings Inc | Mr. Marc Nemati | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 16,667 | 2,565,151 | - | - | - | |
| D-Wave Quantum Inc | Mr. Gregory Golkov | Acting CFO & SVP, Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.03 per share. | 15 Oct 2026 | 15,859 | 411,013 | - | 12.0 | 190,784 | - |
| Ribbon Communications Inc | Mr. Shaul Shani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 15,625 | 253,343 (0%) | 0% | - | - | |
| MapLight Therapeutics Inc | Dr. Erin Pennock Foff, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.08 per share. | 15 Oct 2026 | 15,355 | 296,906 | - | 8.1 | 124,068 | - |
| Nextdoor Holdings Inc (Class A) | Mr. Michael Kiernan | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 15,280 | 505,917 | - | 2.6 | 39,728 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Sophia Schwartz | Chief Legal Officer, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 14,967 | 408,444 | - | 2.6 | 38,914 | - |
| Nexentis Technologies Inc | Ms. Liat Sidi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 14,795 | 15,000 | - | 0 | - | |
| Ribbon Communications Inc | Mr. Eric Marmurek | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 15 Oct 2026 | 14,756 | 566,450 (0%) | 0% | 1.5 | 21,544 | - |
| Clover Health Investments Corp (Class A) | Ms. Karen M. Soares | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.68 per share. | 15 Oct 2026 | 14,673 | 1,592,698 | - | 4.7 | 68,670 | - |
| Synopsys | Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.88 per share. | 15 Oct 2026 | 14,604 | 91,469 (0%) | 0% | 135.9 | 1,984,392 | - |
| Synopsys | Mr. Sassine Ghazi | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 462.84 per share. | 15 Oct 2026 | 14,604 | 76,865 (0%) | 0% | 462.8 | 6,759,359 | - |
| GoodRx Holdings Inc (Class A) | Mr. Justin Fengler | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.38 per share. | 15 Oct 2026 | 14,247 | 70,752 | - | 3.4 | 48,155 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Sophia Schwartz | Chief Legal Officer, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Oct 2026 | 12,302 | 393,938 | - | 2.6 | 31,985 | - |
| MapLight Therapeutics Inc | Dr. Anatol Kreitzer, PhD | Chief Discovery Officer | Sale of securities on an exchange or to another person at price $ 7.84 per share. | 15 Oct 2026 | 12,248 | 168,678 | - | 7.8 | 96,024 | - |
| MiniMed Group Inc | Mr. Robert A. Hopkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 11,877 | 11,877 | - | 0 | - | |
| MiniMed Group Inc | Ms. Amy Bricker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2026 | 11,877 | 11,877 | - | 0 | - | |
| Paylocity Holding Corp | Mr. Steven I. Sarowitz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 165.59 per share. | 15 Oct 2026 | 11,600 | 4,436,795 (8%) | 0% | 165.6 | 1,920,844 | - |
| MapLight Therapeutics Inc | Dr. James Lillie, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.08 per share. | 15 Oct 2026 | 11,513 | 198,597 | - | 8.1 | 93,025 | - |
| Wise Group Plc Ordinary | Mr. Emmanuel Thomassin | Chief Financial Officer and Director | 15 Oct 2026 | 10,893 | 10,893 (0%) | 0% | 0 | - | ||
| Medtronic | Mr. Michael Marinaro | EVP, Pres MedSurg and Americas | Sale of securities on an exchange or to another person at price $ 96.00 per share. | 15 Oct 2026 | 10,420 | 105,916 (0%) | 0% | 96 | 1,000,320 | - |
| Opendoor Tech Inc | Ms. Giang LeGrice | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.97 per share. | 15 Oct 2026 | 10,393 | 8,175,150 | - | 2.0 | 20,516 | - |
| Natera Inc | Dr. Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 404.64 per share. | 15 Oct 2026 | 10,321 | 2,132,868 (2%) | 0% | 404.6 | 4,176,306 | - |
| MapLight Therapeutics Inc | Mr. Jonathan Gillis | CAO and Interim CFO | Sale of securities on an exchange or to another person at price $ 8.08 per share. | 15 Oct 2026 | 10,167 | 142,315 | - | 8.1 | 82,149 | - |
| CarGurus Inc (Class A) | Mr. Samuel Zales | COO and President | Sale of securities on an exchange or to another person at price $ 30.31 per share. | 15 Oct 2026 | 10,000 | 429,735 (0%) | 0% | 30.3 | 303,100 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 15 Oct 2026 | 9,500 | 333,943 (0%) | 0% | 117.8 | 1,118,720 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 9,479 | 18,905 | - | 0 | - | |
| AMN Healthcare Services Inc | Mr. Mark Christopher Hagan | Chief Information and Digital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 9,331 | 54,204 (0%) | 0% | 0 | - | |
| MapLight Therapeutics Inc | Mr. Kristopher L. Hanson | General Counsel | Sale of securities on an exchange or to another person at price $ 8.08 per share. | 15 Oct 2026 | 9,020 | 128,024 | - | 8.1 | 72,882 | - |
| Buckle Inc | Mr. Bill L. Fairfield | Director | Sale of securities on an exchange or to another person at price $ 46.38 per share. | 15 Oct 2026 | 8,500 | 44,408 (0%) | 0% | 46.4 | 394,190 | - |
| BJ`s Wholesale Club Holdings Inc | Ms. Laura L. Felice | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 104.95 per share. | 15 Oct 2026 | 8,452 | 84,416 (0%) | 0% | 104.9 | 887,037 | - |
| Marvell Tech Inc | Mr. Matthew J. Murphy | Director, Chairman of the Board and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 8,409 | 779,894 (0%) | 0% | 0 | - | |
| GrabAGun Digital Holdings Inc | Mr. Matthew Vittitow | Director, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 8,333 | 2,532,567 | - | - | - | |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 15 Oct 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | - |
| QUALCOMM | Mr. Akash J. Palkhiwala | EVP, CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 8,284 | 26,566 (0%) | 0% | 0 | - | |
| QUALCOMM | Mr. Cristiano R. Amon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 178.40 per share. | 15 Oct 2026 | 8,232 | 188,487 (0%) | 0% | 178.4 | 1,468,589 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 8,105 | 23,611 | - | 0 | - | |
| Marvell Tech Inc | Mr. Matthew J. Murphy | Director, Chairman of the Board and CEO | Sale of securities on an exchange or to another person at price $ 235.47 per share. | 15 Oct 2026 | 7,500 | 768,186 (0%) | 0% | 235.5 | 1,766,025 | - |
| Xenon Pharma Inc | Mr. Thomas P. Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 7,500 | 22,500 (0%) | 0% | - | - | |
| Yelp Inc | Mr. David A. Schwarzbach | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 15 Oct 2026 | 7,500 | 172,966 (0%) | 0% | 20 | 150,000 | - |
| Nextdoor Holdings Inc (Class A) | Ms. Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 7,347 | 7,347 | - | 0 | - | |
| Nextdoor Holdings Inc (Class A) | Ms. Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 7,347 | 12,060 | - | 0 | - | |
| Ingredion Inc | Mr. Diego Reynoso | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 97.27 per share. | 15 Oct 2026 | 7,264 | 12,660 (0%) | 0% | 97.3 | 706,569 | - |
| AMD | Mr. Forrest E. Norrod | EVP & GM DSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.85 per share. | 15 Oct 2026 | 7,262 | 370,579 (0%) | 0% | 84.9 | 616,181 | - |
| Walmart | Mr. John R. Furner | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 120.33 per share. | 15 Oct 2026 | 7,089 | 640,825 (0%) | 0% | 120.3 | 852,995 | - |
| Ultragenyx Pharmaceutical Inc | Mr. Howard Horn | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.27 per share. | 15 Oct 2026 | 7,066 | 89,229 (0%) | 0% | 15.3 | 107,898 | - |
| GRAIL Inc | Dr. Joshua Ofman, M.D. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 136.83 per share. | 15 Oct 2026 | 7,052 | 350,419 | - | 136.8 | 964,946 | - |
| Ambiq Micro Inc | Dr. Scott Hanson, PhD | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.12 per share. | 15 Oct 2026 | 7,000 | 219,546 | - | 8.1 | 56,840 | - |
| Oil-Dri Corp Of America | Mr. Christopher B. Lamson | Group Vice President | Sale of securities on an exchange or to another person at price $ 80.27 per share. | 15 Oct 2026 | 7,000 | 4,453 (0%) | 0% | 80.3 | 561,890 | - |
| Marvell Tech Inc | Mr. Matthew J. Murphy | Director, Chairman of the Board and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2026 | 6,968 | 775,154 (0%) | 0% | 0 | - | |
| Paylocity Holding Corp | Mr. Steven R. Beauchamp | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 165.96 per share. | 15 Oct 2026 | 6,800 | 1,243,389 (2%) | 0% | 166.0 | 1,128,528 | - |
| Corcept Therapeutics Inc | Mr. James N. Wilson | Director | Sale of securities on an exchange or to another person at price $ 114.48 per share. | 15 Oct 2026 | 6,654 | 1,057,889 (0%) | 0% | 114.5 | 761,717 | - |
| Flagstar Fin Inc | Mr. George F. Buchanan, III | EVP and Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Oct 2026 | 6,643 | 149,533 (0%) | 0% | 0 | - | |
| Blackstone Mortgage Trust Inc (Class A) | Dr. Lynne B. Sagalyn,PhD | Director | Grant, award, or other acquisition of securities at price $ 10.78 per share. | 15 Oct 2026 | 6,428 | 173,067 (0%) | 0% | 10.8 | 69,294 | - |
| Natera Inc | Dr. Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 402.23 per share. | 15 Oct 2026 | 6,309 | 2,147,047 (2%) | 0% | 402.2 | 2,537,684 | - |
| Natera Inc | Dr. Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 405.18 per share. | 15 Oct 2026 | 6,274 | 2,126,594 (2%) | 0% | 405.2 | 2,542,096 | - |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.